SAGE INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Sage Therapeutics ( NASDAQ:SAGE )
SAN DIEGO, Sept. 01, 2024 ( GLOBE NEWSWIRE ) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sage Therapeutics, Inc.
| Ticker |
Sentiment |
Impact |
|
SAGE
|
Neutral
|
89 %
|
|
BIIB
|
Neutral
|
10 %
|
